Sonographic Evaluation of Early‐Stage Breast Cancers That Undergo Neoadjuvant Chemotherapy

We prospectively evaluated low‐stage breast cancers treated with neoadjuvant chemotherapy using whole‐volume sonography and color Doppler imaging.

[1]  H. Bartelink,et al.  Reproducibility of the assessment of tumor extent in the breast using multiple image modalities. , 2003, Medical physics.

[2]  G L LeCarpentier,et al.  Discrimination of sonographically detected breast masses using frequency shift color Doppler imaging in combination with age and gray scale criteria. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[3]  C. Osborne,et al.  Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Helbich,et al.  Locally advanced breast carcinoma: computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress). , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  T. Hieken,et al.  Correlating sonography, mammography, and pathology in the assessment of breast cancer size. , 2001, American journal of surgery.

[6]  J. Dixon,et al.  Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer , 2002, British Journal of Cancer.

[7]  Hong Zhao,et al.  Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. , 2003, World journal of gastroenterology.

[8]  C. Balu-Maestro,et al.  Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI , 2002, Breast Cancer Research and Treatment.

[9]  B. Asselain,et al.  Neoadjuvant chemotherapy in operable breast cancer. , 1991, European journal of cancer.

[10]  R. Warren,et al.  Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? , 2004, British Journal of Cancer.

[11]  P. Fumoleau,et al.  Original article DOI: 10.1093/annonc/mdg449 Phase , 2022 .

[12]  A. Rademaker,et al.  Prediction of breast cancer size by ultrasound, mammography and core biopsy. , 2004, Breast.

[13]  C. Zuiani,et al.  Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy , 2004, European Radiology.

[14]  W. Yang,et al.  Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. , 1997, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[15]  U. Chetty,et al.  Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment , 1994, The British journal of surgery.

[16]  Robert B Livingston,et al.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  B. Fornage,et al.  Clinical, mammographic, and sonographic determination of preoperative breast cancer size , 1987, Cancer.

[18]  Robert B Livingston,et al.  Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  M. Helvie,et al.  Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. , 1996, Radiology.

[20]  L. Brunereau,et al.  Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  M. Dewhirst,et al.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.

[22]  Barney M. Berlin,et al.  Size , 1989, Encyclopedia of Evolutionary Psychological Science.

[23]  W. Symmans,et al.  Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response. , 2004, Clinical breast cancer.

[24]  P. V. van Diest,et al.  Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. , 1997, American journal of clinical pathology.